Kintara Therapeutics Inc KTRA

Valuation

Market cap

11,913,000

Revenue TTM

$0

Net income TTM

$-8,320,000

P/E (trailing)

—

P/E (forward)

—

Profit margin

—

Debt to equity

—

Trading

Volume

3,700,200

Avg volume

3,026,308

Day's range

$0.20 – $0.24

Shares out

55,305,000

Stochastic %K

64%

Beta

0.82

Analysts

—

Price target

$14.00

Price